Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Extra-hippocampal subcortical limbic involvement predicts episodic recall performance in multiple sclerosis.
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid.
Bone marrow derived elements and resident microglia in brain inflammation.
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism.
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
[Multiple sclerosis and pelviperineology: Urinary and sexual dysfunctions and pregnancy].
Cytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple Sclerosis.
Neuromyelitis Optica with NMO-IgG/Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India.
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
Oxidised LDL lipids, statins and a blood-brain barrier.
Transverse myelitis in a patient with primary antiphospholipid syndrome.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
Pages
« first
‹ previous
…
543
544
545
546
547
548
549
550
551
…
next ›
last »